|
1
|
Niu C, Mei J, Pan Q and Fu X: Nigral
degeneration with inclusion body formation and behavioral changes
in rats after proteasomal inhibition. Stereotact Funct Neurosurg.
87:69–81. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Su YR, Wang J, Wu JJ, Chen Y and Jiang YP:
Overexpression of lentivirus-mediated glial cell line-derived
neurotrophic factor in bone marrow stromal cells and its
neuroprotection for the PC12 cells damaged by lactacystin. Neurosci
Bull. 23:67–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiong N, Zhang Z, Huang J, et al:
VEGF-expressing human umbilical cord mesenchymal stem cells, an
improved therapy strategy for Parkinson’s disease. Gene Ther.
18:394–402. 2011. View Article : Google Scholar
|
|
4
|
Park KW, Eglitis MA and Mouradian MM:
Protection of nigral neurons by GDNF-engineered marrow cell
transplantation. Neurosci Res. 40:315–323. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lindholm P, Voutilainen MH, Laurén J, et
al: Novel neurotrophic factor CDNF protects and rescues midbrain
dopamine neurons in vivo. Nature. 448:73–77. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Airavaara M, Harvey BK, Voutilainen MH, et
al: CDNF protects the nigrostriatal dopamine system and promotes
recovery after MPTP treatment in mice. Cell Transplant.
21:1213–1223. 2012. View Article : Google Scholar
|
|
7
|
Voutilainen MH, Bäck S, Peränen J, et al:
Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat
model of Parkinson’s disease. Exp Neurol. 228:99–108. 2011.
View Article : Google Scholar
|
|
8
|
Woodbury D, Schwarz EJ, Prockop DJ and
Black IB: Adult rat and human bone marrow stromal cells
differentiate into neurons. J Neurosci Res. 61:364–370. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng L, Liu Y, Zhao H, Zhang W, Guo YJ
and Nie L: Lentiviral-mediated transfer of CDNF promotes nerve
regeneration and functional recovery after sciatic nerve injury in
adult rats. Biochem Biophys Res Commun. 18:330–335. 2013.
View Article : Google Scholar
|
|
10
|
Li JM, Zhu H, Lu S, et al: Migration and
differentiation of human mesenchymal stem cells in the normal rat
brain. Neurol Res. 33:84–92. 2011. View Article : Google Scholar
|
|
11
|
Brazelton TR, Rossi FM, Keshet GI and Blau
HM: From marrow to brain: expression of neuronal phenotypes in
adult mice. Science. 290:1775–1779. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muñoz-Elias G, Marcus AJ, Coyne TM,
Woodbury D and Black IB: Adult bone marrow stromal cells in the
embryonic brain: engraftment, migration, differentiation, and
long-term survival. J Neurosci. 24:4585–4595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eglitis MA, Dawson D, Park KW and
Mouradian MM: Targeting of marrow-derived astrocytes to the
ischemic brain. Neuroreport. 10:1289–1292. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee CS, Sauer H and Bjorklund A:
Dopaminergic neuronal degeneration and motor impairments following
axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat.
Neuroscience. 72:641–653. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kirik D, Rosenblad C and Björklund A:
Characterization of behavioral and neurodegenerative changes
following partial lesions of the nigrostriatal dopamine system
induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol.
152:259–277. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lundblad M, Andersson M, Winkler C, Kirik
D, Wierup N and Cenci MA: Pharmacological validation of behavioural
measures of akinesia and dyskinesia in a rat model of Parkinson’s
disease. Eur J Neurosci. 15:120–132. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paxinos G and Watson C: The Rat Brain in
Stereotaxic Coordinates. 2nd edition. Academic Press; San Diego:
1986
|
|
18
|
Rice CM and Scolding NJ: Autologous bone
marrow stem cells - properties and advantages. J Neurol Sci.
265:59–62. 2008. View Article : Google Scholar
|
|
19
|
Benabdallah BF, Allard E, Yao S, et al:
Targeted gene addition to human mesenchymal stromal cells as a
cell-based plasma-soluble protein delivery platform. Cytotherapy.
12:394–399. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schwarz SC and Schwarz J: Translation of
stem cell therapy for neurological diseases. Transl Res.
156:155–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu J, Yu W, Chen Y, et al: Intrastriatal
transplantation of GDNF-engineered BMSCs and its neuroprotection in
lactacystin-induced Parkinsonian rat model. Neurochem Res.
35:495–502. 2010. View Article : Google Scholar
|
|
22
|
Moloney TC, Rooney GE, Barry FP, Howard L
and Dowd E: Potential of rat bone marrow-derived mesenchymal stem
cells as vehicles for delivery of neurotrophins to the Parkinsonian
rat brain. Brain Res. 1359:33–43. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Haleagrahara N, Siew CJ and Ponnusamy K:
Effect of quercetin and desferrioxamine on 6-hydroxydopamine
(6-OHDA) induced neurotoxicity in striatum of rats. J Toxicol Sci.
38:25–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Um JW, Park HJ, Song J, Jeon I, Lee G, Lee
PH and Chung KC: Formation of parkin aggregates and enhanced PINK1
accumulation during the pathogenesis of Parkinson’s disease.
Biochem Biophys Res Commun. 393:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zafar KS, Siddiqui A, Sayeed I, Ahmad M,
Saleem S and Islam F: Protective effect of adenosine in rat model
of Parkinson’s disease: neurobehavioral and neurochemical
evidences. J Chem Neuroanat. 26:143–151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Richter F, Hamann M and Richter A:
Moderate degeneration of nigral neurons after repeated but not
after single intrastriatal injections of low doses of
6-hydroxydopamine in mice. Brain Res. 1188:148–156. 2008.
View Article : Google Scholar
|
|
27
|
Przedborski S, Levivier M, Jiang H,
Ferreira M, Jackson-Lewis V, Donaldson D and Togasaki DM:
Dose-dependent lesions of the dopaminergic nigrostriatal pathway
induced by intrastriatal injection of 6-hydroxydopamine.
Neuroscience. 67:631–647. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zou Z, Jiang X, Zhang W, Zhou Y, Ke Y,
Zhang S and Xu R: Efficacy of Tyrosine Hydroxylase gene modified
neural stem cells derived from bone marrow on Parkinson’s disease -
a rat model study. Brain Res. 1346:279–286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sadan O, Shemesh N, Cohen Y, Melamed E and
Offen D: Adult neurotrophic factor-secreting stem cells: a
potential novel therapy for neurodegenerative diseases. Isr Med
Assoc J. 11:201–204. 2009.PubMed/NCBI
|
